Skip to main content
RecallFDAfda-F-1497-2023OTHER

La Reyna Salsa Verde, Gluten Free / Medium. Product Code 1784. Net Wt 16 oz. UPC 7 52830-92640 0. Ingredients: Tomatillo, Jalapenos,...

Category
Units Affected
720
Recall Date
August 11, 2023
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1497-2023.

Dips and sauces received out of temperature specifications. Product was not quarantined; product was shipped to customers.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1497-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Twin Cities Co-op Partners Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1497-2023.

Twin Cities Co-Op Partners Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Twin Cities Co-op Partners Inc. Recall FAQ

Twin Cities Co-op Partners Inc. is the subject of a produce safety report: La Reyna Salsa Verde, Gluten Free / Medium. Product Code 1784. Net Wt 16 oz. UPC 7 52830-92640 0. Ingredients: Tomatillo, Jalapenos,.... The notice was published on August 11, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 720 units are potentially affected.